Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Melanocytes Found To Contain Olfactory Receptor

XTALKS VITALS NEWS

Skin Cancer

The receptor – which is activated by the olfactory molecule beta-ionone – could be play a role in the development of skin cancer.

Share this!

June 3, 2016 | by Sarah Massey, M.Sc.

Researchers in Germany have identified a specialized scent receptor in the pigment-producing cells of the skin, known as melanocytes. The receptor – which is activated by the olfactory molecule beta-ionone – could be play a role in the development of skin cancer. Tweet: Researchers identified a scent receptor in #melanocytes http://ctt.ec/18c7c+

Using human melanocyte cell cultures, the researchers identified an olfactory receptor known as 51E2. The melanocytes are responsible for producing melanin, a pigment that is released in response to sun exposure and other environmental skin stressors. If melanocytes begin to exhibit signs of unregulated growth however, the excess pigmentation could trigger the development of skin cancer.

In their article, the researchers from Ruhr-Universität Bochum in Germany present the details of the 51E2 olfactory receptor. If the correct odorant binds to the melanocyte’s receptor, a signaling cascade is triggered which increases the cellular concentration of calcium ions.



These calcium ions continue the signaling pathway, at the end of which phosphate groups are transferred to proteins known as MAP-kinases. By regulating enzyme activity, this receptor reaction modulates cell growth and production of melanin.

According to the researchers, the pathway shares similarities to that which occurs when a scent molecular binds to an olfactory receptor in the human nose. The results of this research were published in the Journal of Biological Chemistry.

“The receptor and its activating odor molecule might constitute a new starting point for a melanoma therapy,” said Dr. Hanns Hatt of Bochum's Department for Cell Physiology. While cancerous melanocytes put much of their energy into rapid proliferation, they often stop performing their normal functions which can be influenced by the beta-ionone odorant receptor.

Hatt and his colleagues are currently studying the role of this receptor in melanoma cells collected from patient biopsies. “With its help, we might be able to treat pigmentation disorders of the skin, and they might also be used in tanning products,” said Hatt.


Keywords: Skin Cancer, Melanocytes, Signaling Pathway


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Life Sciences During the Last Week

REGISTER FOR THESE WEBINARS

EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider


Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology


Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn


eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.